Pricing Dispute In Pakistan Over Novartis TB Drug Raises Concern Over Supply Shortfall

Reuters: Pricing dispute hits supply of TB drugs in Pakistan
“Swiss pharmaceuticals firm Novartis AG said it has stopped making tuberculosis drugs in Pakistan in a dispute over pricing, prompting fears of a health crisis due to a shortage of drugs in a country with the world’s fifth-highest TB rates…” (Hashim, 7/19).